Endobloc T Kit Tablet is a prescription combination medication used in the treatment of Pulmonary Arterial Hypertension (PAH) – a life-threatening condition marked by high blood pressure in the lungs’ arteries, causing the heart to work harder. This fixed-dose combination offers a dual mechanism of action to deliver superior benefits over monotherapy.

• Ambrisentan is an endothelin receptor antagonist (ERA) that blocks the effects of endothelin-1, a vasoconstrictor peptide that narrows blood vessels.

• Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor, which increases nitric oxide levels, promoting vasodilation and improved blood flow in pulmonary circulation.

When used together, this combination significantly improves:

• Exercise tolerance

• Pulmonary hemodynamics

• WHO functional class

• Time to clinical worsening

Clinical studies support the combination’s synergistic action in reducing pulmonary artery pressure and right ventricular strain. It is typically recommended for patients with moderate to severe PAH, and those who do not respond adequately to monotherapy.